Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Biosewoom, Inc., Seoul, Republic of Korea.
Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):793-800. doi: 10.1007/s10096-019-03471-9. Epub 2019 Jan 29.
Human adenovirus (HAdV) is a common pathogen causing respiratory infections with outbreaks reported in the military and community. However, little information is available on the shedding kinetics. We performed a prospective study of immunocompetent adults confirmed with HAdV respiratory infection by multiplex real-time PCR during an outbreak of HAdV-55. Consecutive respiratory specimens of sputum or nasopharyngeal swab were collected from each patient every 2 days. Viral load was measured by real-time quantitative PCR. Of 32 enrolled patients, 27 (84.4%) had pneumonia. Five patients (15.6%) received cidofovir. Viral load was highest in the earliest samples at 8.69 log copies/mL. In a linear regression model, viral load declined consistently in a log-linear fashion at the rate of - 0.15 log copies/mL per day (95% confidence interval (CI): - 0.18, - 0.12; R = 0.32). However, the regression model estimated the viral shedding duration to be 55 days. The rate of decline in viral load did not differ between patients who received cidofovir and who did not. Patients with prominent respiratory symptoms or extensive involvement on chest radiograph had higher volume of viral excretion. Prolonged viral shedding was observed in otherwise healthy adults with HAdV-55 respiratory infection. This finding should be considered in the establishment of infection control and prevention strategies.
人腺病毒(HAdV)是一种常见的病原体,可引起呼吸道感染,在军队和社区中均有暴发报道。然而,关于其排毒动力学的信息却很少。我们在人腺病毒 55 型(HAdV-55)暴发期间,对通过多重实时 PCR 确诊的免疫功能正常的成年人进行了一项前瞻性研究。对每位患者连续采集呼吸道痰液或鼻咽拭子标本,每 2 天采集一次。通过实时定量 PCR 测量病毒载量。在 32 名入组患者中,有 27 名(84.4%)患有肺炎。5 名患者(15.6%)接受了更昔洛韦治疗。最早的样本中病毒载量最高,为 8.69 对数拷贝/mL。在线性回归模型中,病毒载量以每天 -0.15 对数拷贝/mL 的速度呈对数线性下降(95%置信区间:-0.18,-0.12;R=0.32)。然而,该回归模型估计病毒排出的持续时间为 55 天。接受更昔洛韦治疗的患者与未接受治疗的患者的病毒载量下降率没有差异。有明显呼吸道症状或胸部 X 线广泛受累的患者病毒排出量较高。在无明显症状的健康成年人中,观察到 HAdV-55 呼吸道感染的病毒排出时间延长。这一发现应在制定感染控制和预防策略时加以考虑。